The Genetic Toxicology Association and the Environmental Mutagen & Genomics Society acknowledge scientists and their contributions to the field.
Our site in Ballina, Ireland, has joined other Charles River facilities and a select group of external institutions by applying for and earning AAALAC accreditation.
The industry has responded to regulatory expectations by introducing more precise and sensitive methods for testing the integrity of container closure systems. Charles River has recently added container closure testing in the US to complement capabilities already established in Europe.
In February, the European Commission and US FDA reached an agreement recognizing the consistency of GMP inspections between the two regulatory bodies. Niall Dinwoodie, Global Coordinator of Analytical Testing, discusses its impact on the release of pharmaceutical products into the US and European markets.
Charles River now offers a rapid quarantine program that significantly reduces animal quarantine time while maintaining added biosecurity.
Our European embryology lab utilises the latest technologies to help manage your transgenic lines, including laser-assisted in vitro fertilization.
These new reporter bioassays offer more reliable, reproducible, and precise surrogate approaches, rather than using the often-variable and inefficient primary mode of action assays.
Exclusive to Charles River, our new HemaTIP™ microsampler simplifies this process by placing the collection media on the tip of an easy-to-hold stylus.
Charles River Microbial Solutions is pleased to announce that it has partnered with Microbiologics®, the leading provider of ready-to-use QC microorganisms, for quality control testing in the clinical, pharmaceutical, food, water and educational industries.
Bioanalysis Zone hosted a panel discussion including experts from Charles River, Millipore Sigma, Neoteryx and more to discuss multiple topics involving microsampling.